Actively Recruiting
Optimization of Cardiac Resynchronization Therapy by Non-Invasive Imaging of Cardiac Electrophysiology
Led by Medical University Innsbruck · Updated on 2025-10-02
25
Participants Needed
1
Research Sites
417 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The principal aim is to analyze total left and right ventricular activation time in different CRT device programming algorithms (SyncAV) measured by non-invasive electrophysiology
CONDITIONS
Official Title
Optimization of Cardiac Resynchronization Therapy by Non-Invasive Imaging of Cardiac Electrophysiology
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients after successful implantation of a CRT-D or CRT-P device with SyncAV programming software
- Left bundle branch block before CRT implantation
- PQ interval 250 ms or less before implantation
- Ability to undergo cardiac magnetic resonance examination
You will not qualify if you...
- High-grade AV block
- Any contraindication for safe cardiac magnetic resonance performance, including claustrophobia
- Terminal heart failure (NYHA IV) or cardiac decompensation
- Life expectancy less than 1 year
- Women with child-bearing potential or pregnancy
- History of drug abuse
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Medical University Innsbruck
Innsbruck, Tyrol, Austria, 6020
Actively Recruiting
Research Team
W
Wolfgang Dichtl, MD PhD
CONTACT
F
Fabian Barbieri, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here